Trial · NCT00665002
Adverse events63
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 63
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Platelets - low | Blood and lymphatic system disorders | Experimental: WT-1 Analog Peptide Vaccine | 10 | 16 | 16 |
| other | Leukocytes (total WBC) - low | Blood and lymphatic system disorders | Experimental: WT-1 Analog Peptide Vaccine | 4 | 16 | 5 |
| other | Neutrophils/granulocytes (ANC/AGC) - low | Blood and lymphatic system disorders | Experimental: WT-1 Analog Peptide Vaccine | 4 | 16 | 12 |
| other | Hemoglobin - low | Blood and lymphatic system disorders | Experimental: WT-1 Analog Peptide Vaccine | 3 | 16 | 7 |
| other | Bone marrow cellularity | Blood and lymphatic system disorders | Experimental: WT-1 Analog Peptide Vaccine | 1 | 16 | 1 |
| other | Injection site reaction/extravasation changes | Skin and subcutaneous tissue disorders | Experimental: WT-1 Analog Peptide Vaccine | 7 | 16 | 19 |
| other | Dermatology/Skin - Other | Skin and subcutaneous tissue disorders | Experimental: WT-1 Analog Peptide Vaccine | 3 | 16 | 3 |
| other | Pruritus/itching | Skin and subcutaneous tissue disorders | Experimental: WT-1 Analog Peptide Vaccine | 2 | 16 | 2 |
| other | Rash: erythema multiforme | Skin and subcutaneous tissue disorders | Experimental: WT-1 Analog Peptide Vaccine | 2 | 16 | 3 |
| other | Bruising (in absence of Grade 3 or 4 thrombocytopenia) | Skin and subcutaneous tissue disorders | Experimental: WT-1 Analog Peptide Vaccine | 1 | 16 | 2 |
| other | Dry skin | Skin and subcutaneous tissue disorders | Experimental: WT-1 Analog Peptide Vaccine | 1 | 16 | 1 |
| other | Flushing | Skin and subcutaneous tissue disorders | Experimental: WT-1 Analog Peptide Vaccine | 1 | 16 | 1 |
| other | Hair loss/alopecia (scalp or body) | Skin and subcutaneous tissue disorders | Experimental: WT-1 Analog Peptide Vaccine | 1 | 16 | 1 |
| other | Fatigue (asthenia, lethargy, malaise) | General disorders | Experimental: WT-1 Analog Peptide Vaccine | 8 | 16 | 10 |
| other | Insomnia | General disorders | Experimental: WT-1 Analog Peptide Vaccine | 1 | 16 | 1 |
| other | Rigors/chills | General disorders | Experimental: WT-1 Analog Peptide Vaccine | 1 | 16 | 1 |
| other | Constipation | Gastrointestinal disorders | Experimental: WT-1 Analog Peptide Vaccine | 4 | 16 | 5 |
| other | Diarrhea | Gastrointestinal disorders | Experimental: WT-1 Analog Peptide Vaccine | 3 | 16 | 3 |
| other | Nausea | Gastrointestinal disorders | Experimental: WT-1 Analog Peptide Vaccine | 3 | 16 | 5 |
| other | Anorexia | Gastrointestinal disorders | Experimental: WT-1 Analog Peptide Vaccine | 2 | 16 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00665002/events